{"name":"Proclara Biosciences, Inc.","slug":"proclara-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQdzNUZFRCTVhoSUllbW1XakkxWEZseVhpUVpUMldwNkhMSGZSR0EtYlFZdTREMG5hVUpPWDRwMEJfNW94eU1JbzdXeUVubkl5MnZtUFZLWTMzME9kbW9yTnFkVWdtQjJLRjVBdWtxeHMyTDh6Rk5peXNDaHUxSWthampFTVdfbVowNExVUmFvMnpOYjlsVGs1MmpLbHlvbW56RmlBOE5zVnZzY2VVYnlrU2dST0k5RmVGTU9GdVI5eDBDd1lURE1vU2tBV1ZuR1lwUzNwanBWS29uNW5qZVVaVGtvT1VkdXVkU2swQlQxQVgtNWVkdk95UEVJUVRycDAzNk9mSjl0b1RZaXV1cGxzSlg1bUE3Q3FTWmVLVFgzWW9YQ2M5amNaeQ?oc=5","date":"2025-02-13","type":"trial","source":"GlobeNewswire","summary":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel - GlobeNewswire","headline":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPNUxrRFEtc3Y4NVJwRzVnZEJNTHl3U1U5djBISDV0T0xWVnpoVE9ZRzBjT1FqOGVTTmJxUWJlNV95Q25ZTG1PUno2QTlYSGdjalNjQjhsWlNHUHRBRm0yUG9zTHAtanZLcmozN2ZtYUxaOTh6cFBnQy04OGt0Z0lCNlZYU3BERU1lWDlvU2pSZXRvUTV6R2ZBM25rYzlsZUJfYUtweHA3VV9RRGIwbktDUXFPQmplMzNSVks4d0dTSEs0X1VnV21tSUNTU01rdDVpR0VxSQ?oc=5","date":"2018-01-03","type":"pipeline","source":"BioSpace","summary":"Proclara Biosciences Strengthens Leadership Team with Appointment of David Michelson, M.D., as Chief Medical Officer - BioSpace","headline":"Proclara Biosciences Strengthens Leadership Team with Appointment of David Michelson, M.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNWVByZVd2VHdQSTc2NlI1MlVhM3hXWHVEVExwclNka0RuTUFDeVlZTDdtYkdSbl9qMEV5WVJ1UzkzTG5pdXhNc0JjTXFHV1ZGNGotQVZNdGZLSTVnVHFYdjNKdHlMWEY0c3pmR1JLR0JMS1Q2QlItVi1keUlLVkRWM2RYejRKTDZjRzlpRGJsZzEyMDZobVJyWlpmM2hFbGJnS2xqMlNvc0ZIVHM?oc=5","date":"2016-09-07","type":"pipeline","source":"Fierce Biotech","summary":"Proclara gets $47M to target protein misfolding in Alzheimer’s and beyond - Fierce Biotech","headline":"Proclara gets $47M to target protein misfolding in Alzheimer’s and beyond","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNekJDZXlhN1dDcml6eXZRZ2Vld0dSYlhlcnd0SDgwbjJwdWxla0J3OXJFYXRpODQ5bllXWktMbU9BSkRlOGhyaF85X2p1OC16bDBIX203S1ByUk50SEh0OVNJSlBRWk9ITzBGQ1VwbFVQbEMzOXJfWm85TUYyTEdTX2JOTDZEZFdrTWQ3N2h0eHMzX2R5cjRoQTdFRWFMcmZjZk5TMzBySlpIaUkzaHdCZmdrYmk0M3QtMVBiX2RpZk1yUQ?oc=5","date":"2016-09-07","type":"trial","source":"BioSpace","summary":"NeuroPhage Transforms Into Proclara, Bags $47 Million and and Launches Phase Ib Alzheimer’s Trial - BioSpace","headline":"NeuroPhage Transforms Into Proclara, Bags $47 Million and and Launches Phase Ib Alzheimer’s Trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}